103 related articles for article (PubMed ID: 8059956)
1. Fluorescent spot test method for specific detection of beta-lactamases.
Chen KC; Chen L; Lin JY
Anal Biochem; 1994 May; 219(1):53-60. PubMed ID: 8059956
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of fluorescence development of end products by use of a fluorescence developer solution in a rapid and sensitive fluorescent spot test for specific detection of microbial beta-lactamases.
Chen KC; Holmes KK
J Clin Microbiol; 1986 Mar; 23(3):539-44. PubMed ID: 3082924
[TBL] [Abstract][Full Text] [Related]
3. Rapid, inexpensive method for specific detection of microbial beta-lactamases by detection of fluorescent end products.
Chen KC; Knapp JS; Holmes KK
J Clin Microbiol; 1984 Jun; 19(6):818-25. PubMed ID: 6381524
[TBL] [Abstract][Full Text] [Related]
4. [Lactamase and bacterial resistance to beta-lactam antibiotics (author's transl)].
Meinardi G; de Carneri I
Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():620-9. PubMed ID: 318023
[TBL] [Abstract][Full Text] [Related]
5. [Current principles of beta-lactamase classification].
Bibikova MV; Ivanitskaia LP; Sazykin AIu
Antibiotiki; 1983 Oct; 28(10):781-95. PubMed ID: 6360034
[No Abstract] [Full Text] [Related]
6. Classification of beta-lactamases.
Bauernfeind A
Rev Infect Dis; 1986; 8 Suppl 5():S470-81. PubMed ID: 3541132
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of multidrug resistant Gram-negative bacilli by Cica-Beta-Test strips.
Lavigne JP; Pfeiffer C; Vidal L; Sotto A
Pathol Biol (Paris); 2011 Feb; 59(1):e7-11. PubMed ID: 20828939
[TBL] [Abstract][Full Text] [Related]
8. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
9. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
[TBL] [Abstract][Full Text] [Related]
10. [Indicator method of determining the beta-lactamase-inhibiting activity of various compounds].
Ivanitskaia LP; Nikishina VG
Antibiotiki; 1981 Apr; 26(4):259-64. PubMed ID: 6972191
[TBL] [Abstract][Full Text] [Related]
11. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
Kim SY; Hong SG; Moland ES; Thomson KS
J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional thin-layer chromatography for simultaneous detection of bacterial beta-lactam acylases and beta-lactamases.
Chen KC
Antimicrob Agents Chemother; 1986 Oct; 30(4):536-41. PubMed ID: 3539008
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of extended-spectrum beta-lactamase-producing Gram-negative bacilli in blood cultures.
Jain S; Andrews J; Fraise A; Brenwald N
J Antimicrob Chemother; 2007 Sep; 60(3):652-4. PubMed ID: 17627966
[TBL] [Abstract][Full Text] [Related]
14. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
16. IRT and CMT beta-lactamases and inhibitor resistance.
Cantón R; Morosini MI; de la Maza OM; de la Pedrosa EG
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():53-62. PubMed ID: 18154528
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
18. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.
Bush K
Clin Infect Dis; 2001 Apr; 32(7):1085-9. PubMed ID: 11264037
[TBL] [Abstract][Full Text] [Related]
19. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
Vinodkumar CS; Neelagund YF
Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
[TBL] [Abstract][Full Text] [Related]
20. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
Jones RN; Biedenbach DJ; Sader HS; Fritsche TR; Toleman MA; Walsh TR
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
